Celldex Therapeutics Inc
SWB:TCE2
Celldex Therapeutics Inc
SWB:TCE2
Price:
28.3
EUR
-3.18%
Market Cap:
€1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
Hunter Group ASA
F:4BD0
|
NO |
|
E
|
Erdene Resource Development Corp
OTC:ERDCF
|
CA |
Shareholder Yield
Current shareholder yield for 
TCE2 is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
TCE2 Price
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Annual Price Range
28.3
52w Low
16.6
52w High
29.23
Price Metrics
| Average Annual Return | 0.7% |
| Standard Deviation of Annual Returns | 27.71% |
| Max Drawdown | -73% |
Shares Statistics
| Market Capitalization | 2.7B EUR |
| Shares Outstanding | 47 264 197 |
| Percentage of Shares Shorted |
N/A
|
TCE2 Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
TCE2's latest stock split occurred on Feb 11, 2019
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, TCE2 traded at 5.115 per share. Afterward, the share price was about 4.09.
The adjusted shares began trading on Feb 11, 2019. This was stock split number 2 in TCE2's history, following the previous one in Mar 10, 2008.
Pre-Split Price
5.115
5.115
Post-Split Price
4.09
Before
After
